Tuesday, September 21, 2010

Session 6: The BioBusiness Revolution 1: Healthcare and the Biomedical Sciences: Past, Present, Future

Brief summary:
-       BioBusiness refers to commercial activity based on an understanding of life sciences and life science processes.
-       We covered these aspects of BioBusiness today:
o   Biomedical BioBusiness
o   Environmental and Industrial BioBusiness
o   Agri-Veterinary and Food BioBusiness
-       Valley and Summit opportunities. Valley: low value-added agriculture; Summit: new innovations like cures for HIV, cloning technology, etc.
-       Healthcare- in the past, it was more corrective than pro-active or preventive. Pre-emptive medicine for people at risk, which can reap huge revenue.


Interesting observations & ideas:
- BioBusiness constitutes over 25% of global GDP! It employs 40% of the world’s labour force
-> Still low value-added; valley opportunities instead of summit opportunities
- Biotechnology has a very broad definition. Traditional biotech would include making beer!
- The Obesity Pandemic – symbolic how technology has destroyed our health and well-being.
- BioBusiness may include cosmetics as well. Prostitution as well, possibly?


Issues for further discussion:
-       “We wont stop being sick until we stop making ourselves sick.” The less we depend on drugs, the more motivated we are to keep healthy.
-       Abuse of BioBusiness: Doping among athletes, abusing human rights in biomedical testing.
-       Ethical issues – Where should we draw the line, and how would we do that?

Key takeaways:
-       The healthcare industry has significant barriers to entry: both specialized knowledge and high costs.
-       BioBusiness may well be our best hope for achieving sustainable development, as it deals with life. Life in the broad sense- of humans, animals and plants.

My ratings for this lesson:
8.5/10. I found the various presentations interesting and insightful. I also liked the ethical debates! However I wish there was more time for discussion and exploration of other related issues, for example how the abuse of BioBusiness can be regulated.

No comments:

Post a Comment